Vext Science, Inc. (CSE:VEXT)
0.280
0.00 (0.00%)
Apr 28, 2026, 3:42 PM EST
Vext Science Revenue
Vext Science had revenue of $12.67M USD in the quarter ending September 30, 2025, with 40.98% growth. This brings the company's revenue in the last twelve months to $47.83M, up 39.78% year-over-year. In the year 2024, Vext Science had annual revenue of $36.00M with 3.40% growth.
Revenue (ttm)
$47.83M
Revenue Growth
+39.78%
P/S Ratio
1.05
Revenue / Employee
n/a
Employees
n/a
Market Cap
70.29M CAD
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Planet 13 Holdings | 141.74M |
| BioNxt Solutions | 15.82K |
| Decibel Cannabis Company | 112.72M |
| Leef Brands | 47.70M |
| LSL Pharma Group | 26.80M |
| C21 Investments | 45.62M |
| ZYUS Life Sciences | 465.00K |
| Medexus Pharmaceuticals | 136.34M |
Vext Science News
- 7 days ago - Vext Announces Revised Date for Q4 and Fiscal 2025 Financial Results Release - Newsfile Corp
- 4 weeks ago - Vext Science Announces Strategic Optimization of Arizona Operations and Plans for Ohio Cultivation Expansion - Newsfile Corp
- 2 months ago - Vext Advances Ohio Expansion with Seventh Retail Location - Newsfile Corp
- 4 months ago - Vext Announces Voting Results of Annual General Meeting - Newsfile Corp
- 5 months ago - CORRECTION FROM SOURCE: Vext Reports Q3 2025 Financial Results - Newsfile Corp
- 5 months ago - Vext Science Earnings Call Transcript: Q3 2025 - Transcripts
- 5 months ago - Vext Reports Q3 2025 Financial Results; Revenue Up 41% Year-over-Year and Operating Cash Flow Year-To-Date Reaches $8.5 Million - Newsfile Corp
- 6 months ago - Vext to Announce Financial Results for Q3 2025 on November 20, 2025 - Newsfile Corp